Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Implitapide in HoFH
NCT00079846Phase 2Terminated
- Sponsor
- Medical Research Laboratories International
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of implitapide in homozygous familial hypercholesterolemia (HoFH), sponsored by Medical Research Laboratories International. Started Sep 2003; status: terminated.
02
Drugs
implitapide
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT00079846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079846.